Australian researchers develop drugs targeting gut bacteria in Parkinson's patients to slow disease progression.
Australian researchers, including those at Queensland University of Technology, are developing drugs that target gut bacteria in Parkinson's patients, aiming to slow or halt the progression of the disease. The research follows evidence suggesting the gut plays a crucial role in Parkinson's development, with studies showing differences in gut ecosystems between patients and healthy individuals.
May 27, 2024
3 Articles